Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-041175

Options or other derivatives

  • Director acquired 16,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
GOWEN MAXINE Director 2019-07-02 Grant or award · Stock option (right to buy) +16,000 16,000 D
Loading xslF345X03/doc4.xml…